Cargando…
SAT-573 Characterization of the Gene Expression Program of a Mutant Thyroid Hormone Receptor in Anaplastic Thyroid Cancer
Thyroid cancer is the most commonly diagnosed endocrine malignancy. Although survival rates for the majority of thyroid cancer subtypes are high compared to other cancers, the de-differentiated anaplastic thyroid cancer (ATC) is particularly aggressive, with a median survival time of less than 6 mon...
Autores principales: | Bolf, Eric, Gillis, Noelle, Tomczak, Jennifer, Stein, Janet, Stein, Gary, Lian, Jane, Frietze, Seth, Carr, Frances |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551908/ http://dx.doi.org/10.1210/js.2019-SAT-573 |
Ejemplares similares
-
SAT-571 Restoration of Thyroid Hormone Receptor Beta Signaling Reprograms Anaplastic Thyroid Cancer Cells
por: Gillis, Noelle, et al.
Publicado: (2019) -
OR21-03 Determining Novel Therapeutic Targets Using an in Vitro Model of TRb Tumor Suppression in Anaplastic Thyroid Cancer
por: Gillis, Noelle E, et al.
Publicado: (2020) -
SAT573 Incidental Discovery Of CHEK2 Mutation With Papillary Thyroid Cancer
por: Thelmo, Franklin L, et al.
Publicado: (2023) -
SUN-573 Plasmapheresis in Thyroid storm
por: Elmahboubi, Riham
Publicado: (2019) -
Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms
por: Davidson, Cole D, et al.
Publicado: (2021)